Centauri Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centauri Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11054
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centauri Therapeutics Ltd (Centauri Therapeutics) is a biotechnology company that discovers and develops novel molecules for life threatening diseases. The company uses alphamer technology to develop anti-infective therapeutics. Its alphamer technology is based on programmable immunity in which chemically synthesised molecules alter the naturally occurring antibodies to selected pathogens to fight against the infection. Centauri Therapeutics also develops alphamers against anti-microbial resistant (AMR) pathogens. It obtains investments from private investors and regional investment funds. The company maintains a network of collaborators in the areas of aptamer selection, drug discovery, chemistry and immunology. It operates through its research and development facility located in Sandwich, Kent. Centauri Therapeutics is headquartered in London, the UK.

Centauri Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Centauri Therapeutics Acquires Alphamer Technology from Altermune Technologies 10
Venture Financing 11
Centauri Therapeutics Raises USD1.5 Million in Second Tranche of Financing 11
Centauri Therapeutics Raises USD4.3 Million in First Tranche of Financing 12
Partnerships 13
Peakdale Molecular Extends Research Agreement with Centauri Therapeutics 13
Horizon Discovery Forms Joint Venture with Centauri Therapeutics 14
Centauri Therapeutics Ltd – Key Competitors 15
Centauri Therapeutics Ltd – Key Employees 16
Centauri Therapeutics Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 18
Corporate Communications 18
Feb 01, 2017: Centauri Board welcomes Jonathan Synett 18
Government and Public Interest 19
Sep 11, 2017: Centauri Therapeutics receives Innovate UK Biomedical Catalyst Award 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centauri Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centauri Therapeutics Acquires Alphamer Technology from Altermune Technologies 10
Centauri Therapeutics Raises USD1.5 Million in Second Tranche of Financing 11
Centauri Therapeutics Raises USD4.3 Million in First Tranche of Financing 12
Peakdale Molecular Extends Research Agreement with Centauri Therapeutics 13
Horizon Discovery Forms Joint Venture with Centauri Therapeutics 14
Centauri Therapeutics Ltd, Key Competitors 15
Centauri Therapeutics Ltd, Key Employees 16
Centauri Therapeutics Ltd, Joint Venture 17

List of Figures
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Centauri Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • West Corporation:企業の戦略的SWOT分析
    West Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • PSA International Pte Ltd:企業の戦略的SWOT分析
    PSA International Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Skyworth Digital Holdings Limited:企業の戦略・SWOT・財務情報
    Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • InterDigital Inc (IDCC):企業の財務・戦略的SWOT分析
    InterDigital Inc (IDCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Sim Lian Group Ltd:企業の戦略・SWOT・財務情報
    Sim Lian Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Sim Lian Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ezz Steel Company SAE:企業の戦略・SWOT・財務分析
    Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report Summary Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FuelCell Energy Inc (FCEL):企業の財務・戦略的SWOT分析
    FuelCell Energy Inc (FCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Trinity Exploration and Production plc (TRIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Trinity Exploration and Production plc (Trinity), formerly Bayfield Energy Holdings plc is an oil and gas company that explores and develops onshore and offshore projects. The company’s activities include production, development, exploration and extraction of hydrocarbons. It operates in Tri …
  • DRDGOLD Ltd:企業の戦略・SWOT・財務情報
    DRDGOLD Ltd - Strategy, SWOT and Corporate Finance Report Summary DRDGOLD Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Medison Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Medison Pharma Ltd (Medison) is marketing company which supplies and markets health care solutions to health maintenance organizations (HMO’s), medical centers, and physicians in Israel and Romania. The company offers pharmaceuticals, medical devices, and diagnostic products in the areas of …
  • Cook Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cook Medical Inc (Cook Medical), that designs, develops and markets medical devices, biological materials and cellular therapies for healthcare market. The company offers products in the fields of critical care medicine, endoscopy, interventional radiology, urology, aortic intervention, lead …
  • Izocam Tic Ve San AS:企業の戦略・SWOT・財務情報
    Izocam Tic Ve San AS - Strategy, SWOT and Corporate Finance Report Summary Izocam Tic Ve San AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ENN Energy Holdings Ltd (2688):企業の財務・戦略的SWOT分析
    ENN Energy Holdings Ltd (2688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Berry Global Group Inc:企業の戦略・SWOT・財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Frigo Pak Gida Maddeleri Sanayi ve Tic.:企業の戦略・SWOT・財務分析
    Frigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report Summary Frigo Pak Gida Maddeleri Sanayi ve Tic. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • Black Hills Corporation:企業の戦略・SWOT・財務分析
    Black Hills Corporation - Strategy, SWOT and Corporate Finance Report Summary Black Hills Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Goldin Financial Holdings Ltd:企業の戦略・SWOT・財務情報
    Goldin Financial Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Financial Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆